Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13D/A | 2024-02-14 | 5AM Ventures VI, L.P. | Vor Biopharma Inc. | 4,595,089 | 6.8% | EDGAR |
SC 13G/A | 2024-02-14 | Paradigm Biocapital Advisors LP | Vor Biopharma Inc. | 6,457,293 | 9.5% | EDGAR |
SC 13G/A | 2024-02-09 | FMR LLC | Vor Biopharma Inc. | 7,618,948 | 11.2% | EDGAR |
SC 13D/A | 2023-08-11 | RA CAPITAL MANAGEMENT, L.P. | Vor Biopharma Inc. | 22,780,343 | 33.7% | EDGAR |
SC 13G/A | 2023-02-14 | Paradigm Biocapital Advisors LP | Vor Biopharma Inc. | 6,477,999 | 9.9% | EDGAR |
SC 13G/A | 2023-01-10 | FMR LLC | Vor Biopharma Inc. | 7,970,511 | 12.1% | EDGAR |
SC 13D/A | 2022-12-09 | RA CAPITAL MANAGEMENT, L.P. | Vor Biopharma Inc. | 22,760,145 | 34.8% | EDGAR |
SC 13D/A | 2022-11-14 | RA CAPITAL MANAGEMENT, L.P. | Vor Biopharma Inc. | 11,131,300 | 28.8% | EDGAR |
SC 13G | 2022-10-27 | Paradigm Biocapital Advisors LP | Vor Biopharma Inc. | 2,328,494 | 6.1% | EDGAR |
SC 13G/A | 2022-02-09 | FMR LLC | Vor Biopharma Inc. | 3,181,463 | 8.5% | EDGAR |
SC 13G | 2021-03-10 | FMR LLC | Vor Biopharma Inc. | 3,935,238 | 10.6% | EDGAR |
SC 13D | 2021-02-19 | RA CAPITAL MANAGEMENT, L.P. | Vor Biopharma Inc. | 11,120,973 | 30.0% | EDGAR |
SC 13D | 2021-02-19 | 5AM Ventures VI, L.P. | Vor Biopharma Inc. | 4,833,959 | 13.0% | EDGAR |